Wound healing activity and mechanisms of action of an antibacterial protein from the venom of the eastern diamondback rattlesnake (Crotalus adamanteus)

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Samy, Ramar Perumal ^a   Kandasamy, Matheswaran ^b   Gopalakrishnakone, Ponnampalam ^a   Stiles, Bradley G ^c,f   Rowan, Edward G ^d   Becker, David ^e   Shanmugam, Muthu K ^a   Sethi, Gautam ^a   Chow, Vincent T K ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b AGENCY FOR SCIENCE   (Singapore)

^c UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^d UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f Wilson College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FIBROBLAST GROWTH FACTOR 2; FUSIDIC ACID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; SNAKE VENOM;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BURKHOLDERIA PSEUDOMALLEI; CELL MIGRATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CROTALUS; CROTALUS ADAMANTEUS; DOWN REGULATION; ENTEROBACTER AEROGENES; ENZYME ACTIVITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MALE; MEMBRANE DAMAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN FIBROBLAST; SKIN INJURY; SPOROGENESIS; STAPHYLOCOCCUS AUREUS; WOUND CLOSURE; WOUND HEALING;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; CELL DEATH; CELL LINE; CELL MEMBRANE; CELL SURVIVAL; COLLAGEN; COLONY COUNT, MICROBIAL; CROTALID VENOMS; CROTALUS; CYTOKINES; EPITHELIUM; HUMANS; INFLAMMATION MEDIATORS; L-LACTATE DEHYDROGENASE; MALE; MICE; MICROBIAL SENSITIVITY TESTS; NF-KAPPA B; SEQUENCE ANALYSIS, PROTEIN; SKIN; WOUND HEALING;

EID: 84895875074     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080199     Document Type: Article

References (78)

1. 2 from the venom of the Saw-scaled viper: Novel bactericidal and membrane damaging activities. Biochime 92(12): 1854-1866.
2. Zaiou M, Nizet V, Gallo RL (2003) Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. J Invest Dermatol 120: 810-816. (Pubitemid 36529083)
3. Reinholz M, Ruzicka T, Schauber J (2012) Cathelicidin LL-37: An antimicrobial peptide with a role in inflammatory skin disease. Ann Dermatol 24(2): 126-135.
4. Morrison G, Kilanowski F, Davidson D, Dorin J (2002) Characterization of the mouse Beta defensin 1, defb1, mutant mouse model. Infect Immun 70: 3053-3060. (Pubitemid 34564166)
5. Bals R, Wilson JM (2003) Cathelicidins-a family of multifunctional antimicrobial peptides. Cell Mol Life Sci 60(4): 711-720. (Pubitemid 36570762)
6. Sandgren S, Wittrup A, Cheng F, Jönsson M, Eklund E, et al. (2004) The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan- dependent endocytosis. J Biol Chem 279: 17951-17956. (Pubitemid 38568102)
7. Lehrer RI, Lichtenstein AK, Ganz T (1993) Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol 11: 105-128. (Pubitemid 23115003)
8. Galbusera E, Renzoni A, Andrey DO, Monod A, Barras C, et al. (2011) Site-Specific mutation of Staphylococcus aureus VraS reveals a crucial role for the VraR-VraS sensor in the emergence of glycopeptide resistance. Antimicrobial Agents and Chemotherapy 55(3): 1008-1020.
9. Desbois AP, Gemmell CG, Coote PJ (2010) In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections. International Journal of Antimicrobial Agents 35(6): 559-565.
10. Micek ST (2007) Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 45 (Supplement 3): S184-S190.
11. Kirby A, Edwards C, Broughton CM, Williams NJ (2011) Glycopeptide and daptomycin resistance in community-associated MRSA in the UK. Infection 39(3): 277-279.
12. Milheirico C, Portelinha A, Krippahl L, de Lencastre H, Oliveira DC (2011) Evidence for a purifying selection acting on the beta-lactamase locus in epidemic clones of methicillin-resistant Staphylococcus aureus. BMC Microbiol 11(76): 1-29.
13. Jikia D, Chkhaidze N, Imedashvili E, Mgaloblishvili I, Tsitlanadze G, et al. (2005) The use of a novel biodegradable preparation capable of the sustained release of bacteriophages and ciprofloxacin, in the complex treatment of multidrug-resistant Staphylococcus aureus -infected local radiation injuries caused by exposure to Sr90. Clinical and Experimental Dermatology 30(1): 23-26. (Pubitemid 40188311)
14. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415(24): 389-395.
15. Perumal Samy R, Pachiappan A, Gopalakrishnakone P, Thwin MM, Hian YE, et al. (2006) In vitro antimicrobial activity of natural proteins and animal venoms tested against Burkholderia pseudomallei. BMC Infect Dis 6(100): 1-16.
16. 2 subunit of croprotein from Crotalus durissus terrificus snake venom, on its enzymatic and pharmacological activities. Int J Biochem Cell Biol 33(9): 877-888.
17. 2 isoform from Crotalus durissus terrificus venom. Toxicon 41(8): 1033-1038.
18. Sampaio SC, Brigatte P, Sousa-e-Silva MCC, dos-Santos EC, Rangel-Santos AC, et al. (2003) Contribution of croprotein for the inhibitory effect of Crotalus durissus terrificus snake venom on macrophage function. Toxicon 41(7): 899-907. (Pubitemid 36627900)
19. Oguiura N, Boni-Mitake M, Affonso R, Zhang G (2011) In vitro antibacterial and hemolytic activities of crotamine, a small basic myotoxin from rattlesnake Crotalus durissus terrificus. The Journal of Antibiotics 64(4): 327-331.
20. 2 with antibacterial activity from Porthidium nasutum snake venom. Comparative Biochemistry and Physiology, Part B 161: 341-347.
21. 2 myoproteins from crotalid snake venoms and their structural determinants of myotoxic action. Toxicon 42: 885-901.
22. 2 from Bothrops pirajai snake venom. Archives of Biochemistry and Biophysics 387(2): 188-196.
23. Nair DG, Fry BG, Alewood P, Kumar PP, Kini RM (2007) Antimicrobial activity of omwaprin, a new member of the waprin family of snake venom proteins. Biochem J 402: 93-104.
24. Pereira HA (2006) Novel therapies based on cationic antimicrobial peptides. Curr Pharm Biotechnol 7: 292-234.
25. Sørensen OE, Cowland JB, Theilgaard-Mönch K, Liu L, Ganz T, et al. (2003) Wound healing and expression of antimicrobial peptides/ polypeptides in human keratinocytes, a consequence of common growth factors. The Journal of Immunology 170: 5583-5589. (Pubitemid 36617848)
26. Behler JL, King FW (1979) The Audubon Society Field Guide to North American Reptiles and Amphibians. New York: Alfred A. Knopf. 743. LCCCN 79-2217.
27. Calvete JJ, Sanz L, Cid P, de la Torre P, Flores-Daz M, et al. (2010) Snake Venomics of the Central American Rattlesnake Crotalus simus and the South American Crotalus durissus Complex Points to Neurotoxicity as an Adaptive Paedomorphic Trend along Crotalus Dispersal in South America. J. Proteome Res 9(1): 528-544.
28. 4. Nature 227: 680-685.
29. Lowry OH, Rosenbrough NJ, Farr AZ, Randall RJ (1951) Protein measurement with the Folin Phenol Reagent. J. Biol Chem 193: 265-275.
30. Bauer AW, Kirby WM, Sherris JC, Turck M (1966) Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 45: 493-496.
31. Perumal Samy R, Gopalakrishnakone P, Vincent Chow TK, Ho B (2008) Viper metalloproteinase (Agkistrodon halys, pallas) with antimicrobial activity against multi-drug resistant human pathogens. J Cell Physiol 216: 54-68. (Pubitemid 351813095)
32. 2 enzymes. J. Applied Microbiol 102: 650-659.
33. Kluver E, Schulz-Maronde S, Scheid S, Meyer B, Forssmann WG, et al. (2005) Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity. Biochemistry 44(28): 9804-9816. (Pubitemid 40994374)
34. Elsinghorst EA (1994) Measurement of invasion by gentamicin resistance. Methods in Enzymology 236: 405-420.
35. Joyce CYC, Duszczyszyn DA, Castellino FJ, Ploplis VA (2001) Accelerated skin wound healing in plasminogen activator inhibitor-1-deficient mice. American Journal of Pathology 159: 1681-1688. (Pubitemid 33062511)
36. Masson P (1929) Trichrome staining and their preliminary technique. J Tech Methods 12: 75-90.
37. Shanmugam MK, Rajendran P, Li F, Nema T, Vali S, et al. (2011). Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice. J Mol Med (Berl) 89(7): 713-727.
38. Galiano RD, Tepper OM, Pelo CR, Bhatt KA, Callaghan M, et al. (2004) Topical Vascular Endothelial Growth Factor Accelerates Diabetic Wound healing through Increased Angiogenesis and by Mobilizing and Recruiting Bone Marrow-Derived Cells. American Journal of Pathology 164(6): 1935-1947. (Pubitemid 38669343)
39. Ishida Y, Kondo T, Kimura A, Matsushima K, Mukaida N (2006) Absence of IL-1 receptor antagonist impaired wound healing along with aberrant NF-kB activation and a reciprocal suppression of TGF-beta signal pathway. The Journal of Immunology 176: 5598-5606.
40. 2 enzymes: classification and characterization. Biochim Biophys Acta 1488: 1-19.
41. 2: The N-Terminal region is more important than enzymatic activity. Biochemistry 45(18): 5800-5816.
42. 2 homologues of snake venoms: biological activities and their possible adaptive roles. Protein and Peptide Letters 16: 860-876.
43. 2 from Crotalus durissus terificus (South American Rattle snake) venom. Protein Journal 24(4): 233-242.
44. 2. Arch Biochem Biophys 284: 352-359.
45. 2 from Agkistrodon acutus venom an ultrahigh resolution, ab initio structure determination. J Biol Chem 278: 41400-41408.
46. 2 neuroproteins and lysophospholipid-fatty acid mixtures. Science 310: 1678-1680.
47. Hara T, Kodama H, Kondo M, Wakamatsu K, Takeda A, et al. (2001) Effects of peptide dimerization on pore formation: antiparallel disulfide-dimerized magainin 2 analogue. Biopolymers 58(4): 437-446. (Pubitemid 32187679)
48. Stocker JF, Travnor JR (1986) The action of various venoms on Escherichia coli. J Appl Bacteriol 61(5): 383-388. (Pubitemid 17220733)
49. Talan DA, Citron DM, Overturf GD, Singer B, Froman P, et al. (1999) Antibacterial activity of crotalid venoms against oral snake flora and other clinical bacteria. J Infect Dis 164(1): 195-198.
50. Santamaría C, Larios S, Quiros S, Pizarro-Cerda J, Gorvel J (2004) Bactericidal and antiendotoxic properties of short cationic peptides derived from a snake venom Lys-49 phospholipase A2. Antimicrob Agents Chemother 49(4): 1340-1345. (Pubitemid 40463359)
51. 2 from crotalid snake venoms and synthetic peptide variants derived from their C-terminal region. Toxicon 45(7): 807-815.
52. 2 from Bothrops asper snake venom. Identification of a heparin-binding and cytolytic protein region by the use of synthetic peptide and molecular modeling. J Biol Chem 269: 29867-29873.
53. 2 from Bothrops asper snake venom: synthetic Lys-49 myoprotein II-(115-129) peptide identifies its bactericidal region. Eur J Biochem 253: 452-461.
54. 2 - derived synthetic peptide variant upon Candida albicans. Rev Esp Quimioter 20(3): 330-333.
55. Stark M, Liu L, Deber CM (2002) Cationic hydrophobic peptides with antimicrobial activity. Antimicrobial Agents and Chemotherapy 46(11): 3585-3590. (Pubitemid 35192930)
56. 2 from Bothrops jararacussu. Toxicon 51(4): 538-546.
57. Koduri RS, Gronroos JO, Laine VJ, Le Calvez C, Lambeau G, et al. (2002) Bactericidal properties of human and murine groups I, II, V, X, and XII secreted phospholipases A2. J Biol Chem 277: 5849-5857. (Pubitemid 34968364)
58. 2. Review. Biochim. Biophys. Acta 1781: 1-9.
59. 2 from Hemachatus haemachatus snake venom - II: Pharmacological properties in relationship to enzymatic activity Biochemical Pharmacology 29(11): 1565-1574.
60. Gosain A, DiPietro LA (2004) Aging and wound healing. World J Surg 28: 321-326. (Pubitemid 38375537)
61. Gabbiani G (2003) The myofibroblast in wound healing and fibrocontractive diseases. The Journal of Pathology 200(4): 500-503.
62. McFarland KL, Klingenberg JM, Boyce ST, Supp DM (2008) Expression of genes encoding antimicrobial proteins and members of the toll-like receptor/nuclear factor-κB pathways in engineered human skin. Wound Repair and Regeneration 16(4): 534-541. (Pubitemid 352000320)
63. Oono T, Huh WK, Shirafuji Y, Akiyama H, Iwatsuki K (2003) Localization of human β-defensin2 and human neutrophil peptides in superficial folliculitis. Br J Dermatol 148: 188-191. (Pubitemid 36114898)
64. Daniels JT, Schultz GS, Blalock TD, Garrett Q, Grotendorst GR, et al. (2003) Mediation of transforming growth factor-{beta}1-stimulated matrix contraction by fibroblasts: a role for connective tissue growth factor in contractile scarring. Am J Pathol 163(5): 2043-2052. (Pubitemid 37310034)
65. Ren HT, Zhang HS (2005) The relationship between scarless wound healing and the expression of CD68 and CD3 in the immunocytes in fetal skin. The Zhonghua Shao Shang Za Zhi 21(5): 356-8.
66. Werner S, Grose R (2003) Regulation of wound healing by growth factors and cytokines. Physiol Rev 83: 835-870. (Pubitemid 36828927)
67. Park JE, Barbul A (2004) Understanding the role of immune regulation in wound healing. Am J Surg 187: 11S-6S. (Pubitemid 38625982)
68. Takamiya M, Biwasakab H, Saigusac K, Nakayashikia N, Aoki Y (2009) Wound age estimation by simultaneous detection of 9 cytokines in human dermal wounds with a multiplex bead-based immunoassay: An estimative method using outsourced examinations. Legal Medicine 11(4): 186-190.
69. Mori R, Kondo T, Ohshima T, Ishida Y, Mukaida N (2002) Accelerated wound healing in tumor necrosis-factor receptor p55-deficient mice with reduced leukocyte infiltration. FASEB J 16: 963-974. (Pubitemid 34753502)
70. Mann A, Breuhahn K, Schirmacher P, Blessing M (2001) Keratinocyte-derived granulocyte-macrophage colony stimulating factor accelerates wound healing: stimulation of keratinocyte proliferation, granulation tissue formation and vascularization. J Invest Dermatol 117: 1382-1390. (Pubitemid 34032763)
71. Szabowski A, Maas-szabowski N, Andrecht S, Kolbus A, Schorpp-kistner M, et al. (2000) c-Jun and Jun-B antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin. Cell 103: 745-755.
72. Karin M, Delhase M (2000) The IκB kinase (IKK) and NF-κB: key elements of pro-inflammatory signalling. Semin. Immunol 12(1): 85-98. (Pubitemid 30114019)
73. Mukaida N (2003) Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol 284: L566-L577.
74. Nakagawa T, Lan HY, Zhu HJ, Kang DH, Schreiner GF, et al. (2004) Differential regulation of VEGF by TGF-β and hypoxia in rat proximal tubular cells. Am J Physiol Renal Physiol, 287: F658-F664. (Pubitemid 39280499)
75. Martin P (1997) Wound healing-aiming for perfect skin regeneration. Science (Wash DC) 276: 75-81.
76. Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, et al. (2004) Vascular endothelial growth factor and angiogenesis. Pharmacological Reviews 56(4): 549-580. (Pubitemid 39658463)
77. Murat Elçin Y, Dixit V, Gitnick G (2001) Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: implications for tissue engineering and wound healing. Artificial Organs 25(7): 558-565. (Pubitemid 33757187)
78. Peters KG, De Vries C, Williams LT (1993) Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 90: 8915-8919. (Pubitemid 23306421)